Anne Coleman to Angiogenesis Inhibitors
This is a "connection" page, showing publications Anne Coleman has written about Angiogenesis Inhibitors.
Connection Strength
0.386
-
Socioeconomic Disparities in Intravitreal Injection Use and Anti-VEGF Agent Selection: Aflibercept/Ranibizumab Versus Bevacizumab. Clin Ther. 2025 Aug; 47(8):559-565.
Score: 0.240
-
Frequency of Bevacizumab and Ranibizumab Injections for Diabetic Macular Edema in Medicare Beneficiaries. Ophthalmic Surg Lasers Imaging Retina. 2018 04 01; 49(4):241-244.
Score: 0.146